2023 HIV Avenir Symposium



Meeting Summary

View the Webinar (2:01:44)
*Note - this webinar is not fully accessible.  If you have difficulty viewing this information and need help, please contact Aaron Neumann.

The NIDA HIV Research Program symposium featured innovative research at the nexus of HIV and substance use disorders led by recipients of Avenir Award Program (DP2) grants (PAR-23-125).

  • Joshua Barocas, M.D., University of Colorado School of Medicine  
    Rethinking What Information Matters and How People Get Counted to Reduce Overdose Deaths
  • Christina Meade, Ph.D., Wake Forest University School of Medicine  
    HIV and Substance Use Comorbidity: From Social to Neural Networks
  • Pablo Penaloza-MacMaster, Ph.D., Northwestern University  
    Developing IFN-Modulated Vaccines to Prevent Intravenous Infections
  • Alon Herschhorn, Ph.D., University of Minnesota  
    Delineation and Vulnerabilities of HIV-1 Escape from Neutralizing Antibodies

You can review the 2022 Avenir Symposium and the 2021 Avenir Symposium, providing insights into other groundbreaking early-stage investigators at the intersection of HIV and substance use. 

HRP also funds the complementary Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research to support potentially transformative studies by investigators at all career levels.

Contact HIVNews@nida.nih.gov for more information and updates on the HIV Avenir and Avant-Garde Awards.